Quality of life in chronic illness: perceptions of parents and paediatricians by Janse, A.J. et al.
ORIGINAL ARTICLE
Quality of life in chronic illness: perceptions of parents and
paediatricians
A J Janse, G Sinnema, C S P M Uiterwaal, J L L Kimpen, R J B J Gemke
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
See end of article for
authors’ affiliations
. . . . . . . . . . . . . . . . . . . . . . .
Correspondence to:
Dr G Sinnema,
Department of Paediatric
Psychology, KA.00.004.0,
Wilhelmina Children’s
Hospital, University
Medical Centre Utrecht,
PO Box 85090, 3508 AB
Utrecht, Netherlands;
G.Sinnema@wkz.azu.nl
Accepted
24 September 2004
. . . . . . . . . . . . . . . . . . . . . . .
Arch Dis Child 2005;90:486–491. doi: 10.1136/adc.2004.051722
Aims: To investigate the differences in perception of quality of life between parents of chronically ill
children and paediatricians at diagnosis and follow up. Quality of life was assessed using the (HUI3).
Methods: Longitudinal study (July 1999–January 2002) of 37 paediatricians and 181 parents of patients
(children aged 1–17 years) with cystic fibrosis admitted for a pneumonia or patients with newly diagnosed
acute lymphatic leukaemia, juvenile idiopathic arthritis, or asthma. Main outcome measure was
percentage agreement on the attributes of the HUI3 between parents and paediatricians.
Results: Differences in perception of health and wellbeing between paediatricians and parents of children
with a chronic disease were found, not only at diagnosis but also after a period of follow up. Differences
were particularly clear in the subjective attributes emotion (range of agreement 28–68%) and pain/
discomfort (range of agreement 11–33%). In all patient groups, at baseline and follow up, the
paediatrician assessed the patient to have less pain/discomfort in comparison to the parents. Despite a
prolonged patient- paediatrician relationship, differences at follow up did not decrease compared to
baseline.
Conclusion: At the onset of a chronic disease, but also after a period of follow up, quality of life of
paediatric patients may be misunderstood by healthcare professionals, especially in the subjective
attributes. Systematic assessment of quality of life may contribute to better understanding between
physicians and parents.
T
o monitor the effectiveness of clinical practice and to
determine the efficacy of new treatment strategies
general indicators of outcome are essential. Physicians
predominantly use conventional clinical, laboratory, and
radiological measures to assess the success of an intervention
and implicitly estimate the wellbeing of the patient. In
addition to these measures the importance of quality of life
(QoL) assessment is increasingly recognised. In randomised
clinical trials QoL is becoming an important secondary
outcome.1–5 As improved treatment leads to substantial gains
in survival rates (for example, in most cancers and cystic
fibrosis), the prevalence of children with a chronic disease is
increasing.6 Differences in perception of the wellbeing of
patients between patients and their physicians may interfere
with the effectiveness of treatment.7 Little is known in the
literature about the differences in perception of wellbeing
between paediatric patients and physicians. A recent meta-
analysis showed that on more objective attributes (sensation,
self-care, and mobility) the agreement between parents and
physicians was higher than on attributes with a subjective
nature (emotion, cognition, and pain/discomfort).8 However,
none of the reviewed studies revealed the direction of the
differences in perception of QoL between parents and
physicians.
The aim of the present longitudinal study was to analyse
the differences in perception of QoL between parents of
chronically ill children and paediatricians at diagnosis and
follow up, and to describe the direction of these differences.
QoL was assessed using the Health Utilities Index mark 3
(HUI3). In children under the age of 10 years, parents
generally act as a proxy for their child. Children 10 years and
older are capable of giving reliable answers about their health
status. However, until the age of 17 years, parents still have a
crucial role in medical decisions concerning their child. In
these decisions, parents rely on their perception of the health
status of their child. Therefore, parents were asked to act as a
proxy and to assess the QoL of their children. Patients with
acute lymphoblastic leukaemia (ALL) were chosen because
the HUI has been successfully used in this group.9–11 Patients
with juvenile chronic arthritis (JIA), cystic fibrosis (CF), and
asthma were included because our hospital aims to be a
centre of excellence for these diseases. Furthermore, we
expected the attributes of the HUI3 to match well with major
complaints of these patients.
We hypothesised that differences in QoL outcomes
between parents and paediatricians would be greatest for
the subjective attributes. We had no a priori expectations
about paediatricians over- or underestimating QoL in
comparison with parents of chronically ill children.
METHODS
Patients
Patients were enrolled at four tertiary care centres
(Wilhelmina Children’s Hospital, University Medical Centre
Utrecht, Utrecht; Sophia Children’s Hospital, Erasmus
University Medical Centre, Rotterdam; Emma Children’s
Hospital, Academic Medical Centre, Amsterdam; and
Asthma Centre Heideheuvel, Hilversum) in the Netherlands
during the period July 1999 to January 2002. Eligibility
criteria included children admitted with newly diagnosed
ALL, children with CF admitted for pneumonia (CF-adm),
children with the diagnosis of JIA or asthma and their first
visit to the outpatient clinic, aged 1–17 years (patients with
asthma, 4–17 years old), and the ability of the parents to
understand and read the Dutch language.
Abbreviations: ALL, acute lymphoblastic leukaemia; CF, cystic fibrosis;
CF-adm, children with CF admitted for pneumonia; HUI3, Health Utilities
Index mark 3; JIA, juvenile chronic arthritis; QoL, quality of life
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Data collection
QoL was assessed using a 42 item interview questionnaire
(baseline) and a 15 item self-complete questionnaire (follow
up) developed for parents. At baseline parents completed the
interview questionnaire administered by the principal inves-
tigator (AJJ). The interview was completed during the first
week following admission (ALL, CF-adm), or after the first
visit to the paediatricians in the outpatient clinic (JIA,
asthma). The follow up assessment was completed after
induction therapy, before the start of methotrexate according
to the SNWLK-ALL-9 protocol (ALL),12 6–8 weeks after
admission (CF-adm), three months after the first visit
(asthma) or six months after the first visit (JIA) in the
outpatient clinic. The follow up interval for each disease was
different and determined by the time needed for stabilisation
of the initial therapeutic effect according to consensus
reached during meetings with clinical experts. In patients
with ALL the follow up time was determined by the SNWLK
protocol.12 Following the consultation or admission of the
patient, the paediatricians completed the Multiattribute
Health Status classification System HUI3 (described by
Feeny et al).13 The paediatricians completed the HUI3
independently from the parents. Parents and paediatricians
were asked to consider the health status of each patient for
the preceding period of four weeks.
Information from these questionnaires was converted to
health state vectors in the HUI3 formats by an established
algorithm.14 The Health Utilities Index mark 2 and mark 3
(HUI2 and HUI3) are generic multiattribute health status
classification systems.13 They have been used in a number of
clinical studies of children with cancer,15–25 extremely low
birth weight infants,26 27 and survivors of paediatric intensive
care.28 The HUI3 has been described in detail by Feeny and
colleagues.13 Briefly, it consists of eight attributes. Each
attribute consists of 5–6 levels representing the range of
functioning from normal (1) to severely impaired (5 or 6).
The attributes forming the HUI3 system are vision (1–6),
hearing (1–6), speech (1–5), ambulation (1–6), dexterity
(1–6), emotion (1–5), cognition (1–6), and pain/discomfort
(1–5). For example, the attribute emotion represents the
following levels: level 1, happy and interested in life; level 2,
somewhat happy; level 3, somewhat unhappy; level 4, very
unhappy; and level 5, so unhappy that life is not worthwhile.
Consent and ethics approval
Written informed consent was obtained from all parents and
of patients over 12 years of age who agreed to participate in
the study. The medical ethics committees of all participating
centres approved the study protocol.
Statistical analysis
Patients were divided into four groups based on their
diagnosis. For each group of patients the following procedure
was used.
Absolute differences between physicians and parents for
each attribute at baseline and at follow up were calculated
using the formula: attribute level physician 2 attribute level
parent. The outcome was dichotomised into presence (‘‘1’’) or
absence (‘‘0’’) of difference between physician and parent.
All outcomes zero become ‘‘0’’, all negative and positive
outcomes become ‘‘1’’. Next, the percentage agreement
between pairs of physicians and parents for each attribute
were calculated exactly. Subsequently, the proportions of
differences between parents and physicians (=percentage
disagreement/100) at baseline (P1) and at follow up (P2) for
each attribute were calculated. The differences in proportions
at baseline and follow up were given by P1–P2, 95% CI were
calculated using the formula P1–P2¡ 1.96* SE [P1–P2].29 95%
CIs for differences in proportions that did not include 0 were
considered statistically significant. A non-parametric test for
paired samples (McNemar test) was used to test the null
hypothesis that differences in perception between parents
and physicians were the same at baseline and at follow up.
Baseline differences in perception for pairs with and without
missing data at follow up were tested using a x2 test (for a
two way frequency table). A p value ,0.05 was considered
statistically significant. The change in the differences (delta)
for each attribute was calculated for all pairs by subtracting
the absolute differences at follow up from the absolute
differences at baseline.
A 10% random sample of all the collected data was taken
(SPSS version 10.0), entered twice into the computer by two
different persons, and verified (SPSS data entry builder
version 1.0). The error rate was acceptable with 0.33%. The
SPSS statistical software (version 10.0) was used for all
calculations.
RESULTS
Study sample
At baseline the parents of 185 of the 187 eligible children
gave consent to participate. Reasons for refusal were the
feeling of interference with the disease (JIA, n=1) and
psychological distress when faced with the diagnosis ALL
(n=1). Four other patients were excluded from further
analysis because the paediatricians did not return the
questionnaire. The final baseline analysis included 181
patients. Complete pairs at follow up were available for 145
of the 181 patients. Reasons for failure to participate at follow
up were death (1 patient), no appointment or not showing up
at the outpatient clinic (26 patients), and no returned
questionnaires (6 patients and 3 physicians). Table 1 shows
characteristics of the study group.
Differences between parents and paediatricians at
diagnosis and follow up
For each group of patients the percentage of pairs with exact
agreement between parents and physicians is given in fig 1.
For all patient groups the agreement for the attributes vision
and hearing were above 90%, in contrast to the agreement for
the attributes pain/discomfort and emotion, which were low
in all groups. There were no baseline differences for patients
without and with missing data. The proportion of differences
for the attribute pain/discomfort in patients with asthma and
the attributes ambulation and emotion in patients with JIA
were significantly lower at follow up than at baseline
(table 2). For all other attributes no significant differences
were found in the proportion of differences at baseline versus
at follow up. Figure 2 shows the direction of the differences
in QoL perception between paediatricians and parents.
Table 1 Patients’ characteristics
Characteristic
Pairs HUI all domains complete 181/145
Mean age first assessment (SD) in years 7.9 (4.3)
Percentage male/female diagnosis (follow up) 83 (70)/54 (75)
Diagnosis (follow up); no. of complete pairs
ALL 47 (40)
Asthma 50 (37)
CF 39 (30)
JIA 45 (38)
Mean duration follow up (weeks)
ALL 7
Asthma 14
CF 9
JIA 28
ALL, acute lymphatic leukaemia; CF, cystic fibrosis admitted for
pneumonia; JIA, juvenile idiopathic arthritis.
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Positive values indicate the paediatrician assessing more
impairment than the parents did, and negative values
represent the parent assessing more impairment than the
paediatrician did. The differences for the attributes vision,
hearing, dexterity, and cognition were relatively small and
are therefore not shown. For the attribute pain/discomfort
the differences were most perspicuous. In all patient groups,
at baseline and follow up, the parents assessed the patient to
have more pain/discomfort than the paediatricians thought
them to have.
DISCUSSION
We have found that differences in the perception of health
between parents of children with a chronic disease and their
paediatricians exist at diagnosis and after a period of follow
up.
In general, the percentage agreement between parents and
physicians for each patient group was found to be higher in
the objective than in the subjective health attributes. Our
earlier findings from the literature showed a pooled
percentage agreement of 84–89% for the objective attributes
and of 69–77% for the subjective domains.8 In the present
study the agreement for the attribute pain/discomfort was
remarkably low for all patient groups. For the attribute
emotion, the agreement was lower than expected from the
literature.8 Probably, in our study the agreement for these
attributes was low because most patients consulted the
physician in the acute phase of the disease, whereas in the
literature the HUI has been used mostly in survivors of
childhood cancer.15–20 23–25 It is known from the literature that
QoL of patients can change dramatically during treatment.
For example, the QoL of children with recurrent acute otitis
media and/or chronic otitis media with effusion significantly
improved after surgical intervention,30 whereas the QoL of
children with chronic viral hepatitis temporarily deteriorated
during alpha-interferon therapy.31 Also, differences in per-
ception of QoL between parents and physicians and the
magnitude of these differences are likely to be susceptible to
change in time. In a study of adults with cancer it was found
that the agreement for the more private domains (such as
feelings, social functioning, overall QoL, and pain/discom-
fort) was slightly higher at follow up than at baseline. Firstly,
it is suggested that monitoring the patients’ QoL over time
may increase the caregivers’ awareness of wellbeing of the
patient.32 Secondly, the objective domains are visible and
more concrete than the subjective domains. Therefore, a
higher agreement can be expected in the former.33 However,
in our study the agreement did not essentially change over
follow up periods, although patients were treated for their
acute symptoms and patients and physicians became
acquainted to each other. At follow up the rates of
(dis)agreement remained fairly stable. Only for patients with
asthma (pain/discomfort) and for patients with JIA (ambula-
tion and emotion) did the agreement improve at follow up.
We found obvious differences in four of the eight attributes.
Paediatricians rated more emotional problems (ALL, CF, JIA)
and problems with ambulation (JIA). Parents rated more
pain/discomfort (all patient groups) and speech impairments.
Percentage agreement
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Figure 1 Percentage agreement between paediatricians and parents of chronically ill children (ALL, asthma, CF, and JIA) for each HUI3 attribute at
baseline and follow up.
488 Janse, Sinnema, Uiterwaal, et al
www.archdischild.com
In our study we did not use the children’s’ assessment of
their quality of life. However, for the attribute pain/
discomfort it is known from the literature that physicians
have the tendency to underestimate the intensity of the
patient’s pain/discomfort.32 34–36 A possible explanation for the
disagreement on speech impairment is that in young children
paediatricians tend to interpret HUI level 1 as language
development according to age, while parents scored level 3 as
development according to age.
Before further interpretation of our results, some metho-
dological issues need to be addressed. A strong feature of our
study is that the participation rate was high and that it had
very few missing data at baseline. Furthermore, we used a
validated instrument to measure quality of life as judged by
both physicians and the parents. Physicians completed the
assessments independent from parental HUI measurements.
Some other points need attention. Complete follow up data
were available for 80% of the patients. Because the
differences in perception of QoL at baseline were the same
for patients with and without complete follow up data, we
expect our results to be valid. Each paediatrician (n=37)
completed the HUI several times (range 1–34). In 90 patients
the same paediatricians completed the assessment both at
baseline and at follow up. Due to a learning effect of the
paediatrician the percentage agreement in this study might
be higher than would have been found in regular clinical
practice. The HUI has been validated originally for children of
6 years and older.13 For young children only a few QoL
questionnaires are available (Functional Status, RAND, and
the TAPQOL).37–39 In a study assessing the health status in a
heterogeneous population of children admitted to intensive
care, it seemed feasible to classify children over 1 year of age
reliably, using the HUI by an observer well known to the
patient.40 In our study the HUI3 questionnaire was adminis-
tered to the parents by an interviewer at baseline and was
self-completed at follow up while the HUI3 was self-
completed by the paediatricians (both assessments). In the
literature different results are reported about the effect of the
mode of administration of HRQoL questionnaires.
Grootendorst et al found that subjects participating in the
Ontario Health Study, completing the interviewer adminis-
tered form, reported less dysfunction than subjects complet-
ing the self-reported form.41 However Verrips et al reported
that the mean number of affected attributes was higher and
the mean utility score was lower when children (preterm
born infants now 14 years old) and proxies were interviewed
than when they self-completed the questionnaire.27 Both
studies used the HUI3 to assess the health status. In our
study the participating paediatricians preferred the self-
completed form because of their time schedule at the
outpatient clinic.
With regard to the implications of our study, we conclude
that QoL should be given a fair amount of attention in
chronic paediatric illnesses. Good medical practice requires
an optimal relationship between physicians, patients, and
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Figure 2 Number of pairs of disagreement between paediatricians
and parents of chronically ill children (ALL, asthma, CF, and JIA) for
the HUI3 attributes speech, ambulation, emotion, and pain/discomfort.
The HUI3 attribute levels of the parents were subtracted from the levels
of the paediatricians. The positive bars represent the number of pairs
for each attribute where the paediatrician scored a higher level of
impairment within attributes than the parent at baseline (1; black) and
at follow up (2; dark grey). The negative bars represent the number of
pairs where the parent scored a higher level of disturbances within
attributes than the paediatrician at baseline (1; grey) and at follow up
(2; white).
Table 2 Proportion and change of differences at
baseline and follow up
Diagnosis Attribute P1–P2 95% CI P1–P2
Asthma Pain/discomfort 0.23 0.05 to 0.39
JIA Ambulation 0.26 0.07 to 0.44
JIA Emotion 0.28 0.08 to 0.48
The proportions of differences between parents and physicians at
baseline (P1) and at follow up (P2) for each attribute were calculated. The
differences in proportions at baseline and follow up were given by P1–P2,
95% CI were calculated using the formula P1–P2 ¡ 1.96* SE [P1–P2].
29
Only attributes with 95% CI excluding zero were shown.
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parents for mutual understanding of the impact of the
disease. Whatever the reasons for discrepancies of perception,
physicians should be aware that parents and physicians may
look differently at the impact of the disease. This is
particularly important for discrepancies pertaining to the
attributes emotion and pain, which are vital to the child’s
wellbeing. Physicians have the tools to improve on this, by
better and more explicitly discussing these issues with
patients and parents. As differences in perception of QoL
between parents and physicians may be different for various
countries/populations, replication studies are needed. QoL
evaluation may have a prominent role in assessing the
changes of a patient’s condition in the natural course of the
disease or in the follow up of therapeutic interventions. In
this way, better mutual understanding of perception of QoL
between physician and the parents of the patient may
enhance effects of treatment.
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a paper version and on the internet. Clinical Evidence needs to recruit a number of new
contributors. Contributors are healthcare professionals or epidemiologists with experience in
evidence-based medicine and the ability to write in a concise and structured way.
Areas for which we are currently seeking authors:
N Child health: nocturnal enuresis
N Eye disorders: bacterial conjunctivitis
N Male health: prostate cancer (metastatic)
N Women’s health: pre-menstrual syndrome; pyelonephritis in non-pregnant women
However, we are always looking for others, so do not let this list discourage you.
Being a contributor involves:
N Selecting from a validated, screened search (performed by in-house Information
Specialists) epidemiologically sound studies for inclusion.
N Documenting your decisions about which studies to include on an inclusion and exclusion
form, which we keep on file.
N Writing the text to a highly structured template (about 1500–3000 words), using evidence
from the final studies chosen, within 8–10 weeks of receiving the literature search.
N Working with Clinical Evidence editors to ensure that the final text meets epidemiological
and style standards.
N Updating the text every six months using any new, sound evidence that becomes available.
The Clinical Evidence in-house team will conduct the searches for contributors; your task is
simply to filter out high quality studies and incorporate them in the existing text.
N To expand the topic to include a new question about once every 12–18 months.
If you would like to become a contributor for Clinical Evidence or require more information
about what this involves please send your contact details and a copy of your CV, clearly
stating the clinical area you are interested in, to Klara Brunnhuber (kbrunnhuber@
bmjgroup.com).
Call for peer reviewers
Clinical Evidence also needs to recruit a number of new peer reviewers specifically with an
interest in the clinical areas stated above, and also others related to general practice. Peer
reviewers are healthcare professionals or epidemiologists with experience in evidence-based
medicine. As a peer reviewer you would be asked for your views on the clinical relevance,
validity, and accessibility of specific topics within the journal, and their usefulness to the
intended audience (international generalists and healthcare professionals, possibly with
limited statistical knowledge). Topics are usually 1500–3000 words in length and we would
ask you to review between 2–5 topics per year. The peer review process takes place
throughout the year, and our turnaround time for each review is ideally 10–14 days.
If you are interested in becoming a peer reviewer for Clinical Evidence, please
complete the peer review questionnaire at www.clinicalevidence.com or contact Klara
Brunnhuber (kbrunnhuber@bmjgroup.com).
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